SEC reporting owner
| Reporting owner CIK | 0001543895 |
|---|---|
| Issuers | 2 |
| Qualifying disclosures | 13 |
| Public purchases | 0 |
| Recent-window purchases | 0 |
| Recent-window sales | 3 |
| Last public filing | 2026-09-11 |
| Coverage | verified |
| Directory rank | 13,054 |
| Publicly available | Trade date | Ticker | Code | Shares | Reported value |
|---|---|---|---|---|---|
| 2026-09-11 | 2026-09-11 | CG | S | 400,000 | Not reported |
| 2026-05-08 | 2026-05-06 | MRNA | A | 2,092 | Not reported |
| 2026-05-08 | 2026-05-06 | MRNA | A | 9,681 | Not reported |
| 2026-03-20 | 2026-03-19 | CG | S | 500,000 | Not reported |
| 2025-12-12 | 2025-12-10 | CG | S | 625,000 | Not reported |
| 2025-05-01 | 2025-04-30 | MRNA | A | 8,116 | Not reported |
| 2025-05-01 | 2025-04-30 | MRNA | A | 12,756 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.